Product "LICEL" classified as "Medicament" under Chapter 30, not insecticide. Court emphasizes accurate tariff classification.

The Court upheld the Tribunal's decision to classify the product "LICEL" under tariff sub-heading 3003.10 instead of 3808.10. Despite being perceived as an insecticide, the product's therapeutic and prophylactic purposes qualified it as a "Medicament" under Chapter 30, excluding it from Chapter 38. The Court emphasized the importance of adhering to specific definitions and criteria in tariff headings for accurate classification, considering a product's intended use over common perception. Previous judgments and legislative intent supported the Court's ruling, dismissing the Civil Appeal.

---

---

Issues: Classification of a product under tariff sub-heading 3808.10 or 3003.10.

In this judgment, the issue revolves around the classification of a product known as "LICEL" by the Appellants. The Appellants claim that their product should be classified under tariff sub-heading 3808.10, while the Department argues that it should be classified under tariff sub-heading 3003.10. The Tribunal, relying on a previous judgment concerning a similar product, held that the product falls under tariff sub-heading 3003.10. The Appellants contest this classification based on chemical examiners' reports and market perception of the product as an insecticide. However, the Court analyzes the definition of "Medicament" under Chapter 30, emphasizing that even if a product is perceived as an insecticide, if it has therapeutic or prophylactic use, it cannot be classified under Chapter 38. The Court concludes that LICEL, used for killing lice in human hair, serves therapeutic and prophylactic purposes, making it a Medicament under Chapter 30 and excluding it from Chapter 38. This interpretation is consistent with a previous case involving a similar product. Consequently, the Court upholds the Tribunal's judgment, dismissing the Civil Appeal.

This judgment highlights the importance of understanding the specific definitions and criteria outlined in the tariff headings and chapter notes for the proper classification of products. It underscores the significance of the therapeutic and prophylactic use of a product in determining its classification, even if it is commonly perceived as something else, such as an insecticide. The Court's analysis focuses on the legislative intent behind the classification system and the need for a comprehensive assessment of a product's intended use to ensure accurate classification under the relevant tariff sub-headings. The reference to previous judgments and consistency in interpretation further solidify the Court's decision in this case.

---